 - Previous therapy with GS-1101 CAL-101, Idelalisib, IPI-145 Duvelisib, TGR-1202 or any drug that specifically inhibits PI3K mTOR including temsirolimus, everolimus, AKT or BTK Inhibitor including Ibrutinib in last 6 months 